Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank33
Studio
Year-over-Year Change

Free cash flow yield

Latest
-61.57%
Near historical average
Percentile
P33
Within normal range
Streak
2 yr
Consecutive growthNormalizing
Average
-60.28%
Historical baseline
PeriodValueYoY Change
2024-61.57%+26.7%
2023-84.05%+62.1%
2022-221.72%-484.2%
2021-37.95%-604.1%
2020-5.39%-9.0%
2019-4.94%+21.8%
2018-6.32%-